Reduction of epidermal abnormalities and inflammatory changes in psoriatic plaques during treatment with vitamin D3 analogs

Journal of Investigative Dermatology Symposium Proceedings

Volumn 1, Issue 1, 1996, Pages 78-81

  Van De Kerkliof, Peter C M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Calcitriollcalcipotriolltacalcitol

Indexed keywords

1 ALPHA,24 DIHYDROXYVITAMIN D3; 1 ALPHA,24-DIHYDROXYVITAMIN D3; CALCIPOTRIOL; CALCITRIOL; DIHYDROXYCOLECALCIFEROL; DRUG DERIVATIVE;

CHEMISTRY; DRUG EFFECT; EPIDERMIS; FLOW CYTOMETRY; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATION; PATHOLOGY; PSORIASIS; REVIEW;

CALCITRIOL; DIHYDROXYCHOLECALCIFEROLS; EPIDERMIS; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; PSORIASIS;

EID: 0030112284     PISSN: 10870024     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Bauer FW, Boezeman JBM: Flow cytometric methods in human skin with respect to cell cycle kinetics. In: Wright NB, Camplejohn RS (eds.). Psoriasis: Cell Proliferation. Churchill Livingstone, Edinburgh, 1983, pp 104-116
2. Bauer F\V, Crombach NHCMN, Boezeman JBM, de Grood RM: Flow cytometry as a tool for the study of cell kinetics in skin. Cell kinetic data in psoriasis, lir J Dennatol 104:271-276, 1981
3. Bauer FW, Crombach NHCMN, de Grood RM: Quantification of deviations of the epidermal DNA distributions in psoriasis and the effect of therapy. Flow Cytoinary 4:377-381, 1980
4. BerthJonesJ, BourkcJ, Bailey K, Graham Brown RAC, Hutchinson PE: Generalised pustular psoriasis: response to topical calcipotriol. BMJ 305:868-869, 1992
5. Berth Jones J, Fletcher A, Hutchinson PE: Epidermal cytokeratin and immunocyte responses during treatment of psoriasis with calcipotriol. In: Norman AW, Bouillon R, Thomass M (eds.). Vitamin D: Cette Regulation Structure Function Analysis, Clinical Applications. De Gruyter, Berlin, 1991, pp 424-425
6. Binderup L, Bramm E: Effects of a novel vitamin D analogue MC 903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivo. Bixhem Pliarmacol 37:889-895, 1988
7. Binderup L, Kragballe K: Origin of the use of calcipotriol in psoriasis treatment. Rev Conlemp Pliannacother 3:357-365, 1992
8. Brittiner B, Bleehen SS, MacNeil S: la,25-(OH)2-vitamin D3 increases intracellular calcium in human keratinocytes. BrJ Dennatol 124:230-235, 1991
9. de Jong EMGJ, Femer C, Wauben-Penris PJJ, Korstanje C, van de Kerkhof PCM: Effects of topical treatment of Budesonide on parameters for epidermal prolifer-ation, keratinization and inflammation in psoriasis. J Dertnatol Sei (in press)
10. de Jong EMGJ, van de Kerkhof PCM: Short contact dithranol treatment of psoriasis, using a novel emulsifying ointment (Hennal-AW1): changes in clinical scores and in parameters for inflammation, proliferation, keratinization. EurJ Dennatol 2:552-558, 1992
11. de Jong EMGJ, van de Kerkhof PCM: Simultaneous assessment of inflammation and epidermal proliferation in psoriatic plaques during long term treatment with vitamin D3 analogue MC 903: modulations and interrelations. Ur J Dennatol 124:221-229, 1991
12. de Jong EMGJ, van Vlijmen-Willems IMJJ, van Erp PEJ, Ramaekers PCS, van de Kerkhof PCM: Keratin 17: a useful marker in psoriatic therapies. Arch Dennatol Res 283:480-482, 1991
13. de Mare S, de Jong EMGJ, van de Kerkhof PCM: DNA content and Ks 8.12 binding of the vitamin D3 analogue MC 903 and betamethasone. DrJ Dennatol 123:291-295, 1990
14. Gerritsen MJP, Boezeman JBM, van Vlijmen-Willems IMJJ, van de Kerkhof PCM: The effect of tacalcitol (l,24-(OH)2-Dj) on cutaneous inflammation, epidermal proliferation and keratinization in psoriasis: a placebo controlled, double blind study. BrJ Dennatol 286:455-461, 1994
15. Gerritsen MJP, Rulo HFC, van Vlijmen-Willems IMJJ, van Erp PEJ, van de Kerkhof PCM: Topical treatment with la, 25-dihydroxy-cholecalciferol: a cell biological study. Dr J Dmnatol 128:666-673, 1993
16. Gerritsen MJP, van Erp PEJ, van de Kerkhof PCM: Transglutaminase positive cells in psoriatic epidermis during treatment with calcitriol and tacalcitol. BrJ Dennatol in press
17. Glade CP, van Erp PEJ, van Hooijdonk CAEM, van de Kerkhof PCM: Topical treatment of psoriatic plaques with la, 24-dihydroxy vitamin Dj: a multiparam eter flow cytometrieal analysis of epidermal growth, differentiation and inflammation. Acta Denn Venereol (Stockh) in press
18. Gupta S, Pass O, Shimuzu M, Vayuvegula B: Potentiation of immunosuppressive effects of cyclosporin A by 1, 25-dihydroxy \-itamin D3. Cell Immimol 121:290-297, 1989
19. 3 analogue MC 903. BrJ Derinatol 122:284, 1990
20. Hosomi J, Hosoi J, Abe E, Suda T, Kuroki T: Cultured mouse epidermal cells by 1α, 25-dihydroxyvitamin D3. Endocrinology 113:1950-1957, 1983
21. Hustmyer FG, Benniger L, Manolagas SC: Comparison of the effects of 22-oxa-l,25 (OH)2D3 and MC903 on the production of IL-6, gamma-IFN and T lymphocyte proliferation in peripheral blood mononuclear cells. J Bone Miner Res 6:S292-S298, 1991
22. 3 signalling. Nature 355:446-449, 1992
23. Kragballe K, Steijlen PM, van de Kerkhof PCM, Esman J, Sorensen LH, Ibsen HH, Axelsen MB: Efficacy, tolerability and safety of calcipotriol ointment in disorders of keratinization. Arch Demtatol 131:556-560, 1995
24. Kragballe K, Wildfang IL: Calcipotriol, MC 903, a novel vitamin D3 analogue, stimulates terminal differentiation and inhibits proliferation of cultured human keratinocytes. Arch Dennatol Res 282:164-167, 1990
25. Langner A, VerJans H, Stapor V, Mol M, Frazykowska M: la, 25-dihydroxy vitamin Dj calcitriol ointment in psoriasis. J Dennalol Treat 3:177-184, 1992
26. Lee SC, Ikai K, Ando Y, Imamura S: Effects of 1 alpha, 25-dihydroxy vitamin D3 on the transglutaminase activity of transformed mouse epidermal cells in culture. J Dennatol 16:7-11, 1989
27. Leman J Jr, Gray RW: Calcitriol, calcium and granulomatous disease. N Engl J Med 311:1115-1117, 1984
28. Lemire JM: Immunomodulatory role of 1,25-dihydroxy vitamin D3. J Cell Biocliem 49:26-31, 1992
29. MacLaughlin JA, Cantley LC, Holick MF: 1,25(OH)2D3 increases calcium and phosphatidylinositol metabolism in differentiating cultured human keratinocytes. J Kurr Bioclttm 1:81-87, 1990
30. Malet RB, Coulson IH, Purkis PE: An immunoliistochemical analysis of changes in the immune infiltrate and keratin expression in psoriasis treated with calcipotriol compared with betamethasone ointment. BrJ Dennatol 123:837, 1990
31. 3, a novel active form of vitamin D3 with high activity for inducing epidermal differentiation but decreased hypercalcémie activity. J Dennatol 17:135-142, 1990
32. Nishinura M, Hori Y, Nishiyama S, Nakamizo Y: Topical 1α, 24 (R)-dihydroxy vitamin D3 for the treatment of psoriasis. Review of the literature. EiirJ Dcrtnatol 3:255-261, 1993
33. 3 and retinoic acid in the regulation of CD 14 and CD23 expression during monocydc differentiation of U-937 cells. J Immunol 150:3487-3495, 1993
34. Oxholm A, Oxholm P, Staberg B, Bendtzen K: Expression of înterIeukin-6-like molecules and tumour necrosis factor after topical treatment of psoriasis with a new vitamin D analogue (MC903). Acta Denn Vencreol (Stockh) 69:385-390, 1989
35. Ozone K, Sone T, Pike JW: The genomic mechanism of action of 1,25-dihydroxy vitamin D3. J Bone Miner Res 6:1021-1027, 1991
36. Petrini M, Dastoli G, Valentini P, Mattii L, Trombi L, Testi R, Ambrosi F, Grossi B: Synergetic effects of alpha interferon and 1,25 dihydroxy \-itamin D3: preliminary evidence suggesting that interferon induces expression of the vitamin D receptor. Haematologifa 76:467-471, 1991
37. Régnier M, Darmon M: 1,25 Dihydroxy vitamin D3 stimulates specifically the last steps of epidermal differentiation of cultured human keratinocytes. Differentiation 47:173-188, 1991
38. 3 and minerals on the synthesis of leukotriene B4 and 5-hydroxy eicosatetraenoic acid by rat peritoneal neutrophils. Prostaglantlins Leukot Essent Fatty Adds 32:9-14, 1988
39. 2 vitamin D3. Nippon Hifuka Gakkai Zasshi 101:519-525, 1991
40. Tsoukas CD, Provedini DM, Manolagas SC: 1,25-dihydroxy vitamin D3: a novel immunoregulatory hormone. Science 224:1438-1440, 1984
41. Ueda K, Suzuki H, Nakagawa S, Kawahara K: Light microscope and electron microscope studies on the guinea pig skin on the lesions of psoriasis vulgaris after topical application of la, 24-dihydroxy vitamin D3. Acta Dcrmatol (Kyoto) 84:341-358, 1989
42. van Erp PEJ, Rijzcwijk JJ, Boezeman JBM: Flow cytoiuctric analysis of epidermal subpopulations from normal and psoriatic skin using monoclonal antibodies against intermediate filaments. Am J Pathol 135:865-870. 1989
43. van Hooijdonk CAEM, Glade CP, van Erp PEJ: TO-PRO-3 iodide, a novel HeNe laser-excitable DNA stain as an alternative for propidium iodide in multiparameter flow cytometry. Cytometry in press
44. Verburgh CA, Nieboer CA: Local apph'carion of vitamin D derivarive MC903 in psoriasis: influence on cellular infiltrate, Langerhans cells and keratinocytc markers.,/ Invest Dermatol 93:310, 1989
45. Yada Y, Ozeki T, Meguro S: Signal transduction in the onset of terminal keratinocyte differentiation induced by 1,25-dihydroxy vitamin D3: role of protein kinase C translocation. Bioctiem Biophys Res Commun 163:1517-1522, 1989